According to the latest report published by Credence Research, Inc. “Angioedema Treatment Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the angioedema market was valued at USD 895.4 Mn in 2015, and is expected to reach USD 1,658.0 Mn by 2022, expanding at a CAGR of 9.2% from 2016 to 2022.
Browse the full report Angioedema Treatment Market Growth, Future Prospects and Competitive Analysis, 2016-2022report at http://www.credenceresearch.com/report/angioedema-treatment-market
Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. North America is the largest regional market at a market share of over 41% in 2015, and the dominance of this region is anticipated to continue through 2022. Rising incidence of angioedema and high awareness about treatment and the management of angioedema together drive the North America angioedema market.
Asia Pacific is expected to be the fastest growing market in the global angioedema market due to rising prevalence rate in the countries like Japan, China and others. Moreover, the growing research and development in the drug discovery of angioedema would further drive the market during the forecast period.
The treatment types include Antihistamines, Corticosteroids, Autoimmune drugs, antifibrinolytic agents and blood protein controllers. Antihistamines and Corticosteroids accounted for approximately 45% – 50% of the total market share because these are the first line therapies preferred by the medical practitioners and majorly used as supportive therapies and most accessible source of treatment across the globe.
Browse the full report at http://www.credenceresearch.com/report/angioedema-treatment-market
Despite the high cost of new treatment options in comparison to older therapies such as attenuated androgens and antifibrinolytic agents, they are popular with physicians due to the superior control offered over symptoms such as subcutaneous and abdominal swelling. These highly priced drugs have therefore managed to capture a high prescription share. Hence, introduction of new drugs with further improved effectiveness and safety will drive the global angioedema market during the forecast period.
Video Conferencing in Healthcare Market By Deployment Model (On-premise Video Conferencing, Cloud-based Video Conferencing, Managed Video Conferencing Services) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022
Telehealth Market By Components (Telehealth Services, Telehealth Hardware, Telehealth), By Services (Tele-Consultation, Tele-Monitoring, Tele-Education, Tele-Training, Tele-Care, Tele-Surgery, Tele-Radiology), By Type (Services, Hardware, Software), By Aplication (Tele-Consultation, Tele-Monitoring, Tele-Education, Tele-Training, Tele-Care, Tele-Surgery, Tele-Radiology) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022
Listeria Monocytogenes Infections Treatment Market By Type Of Infection (Bacteremia, Meningitis, Brain Abscess, Gastroenteritis, Endocarditis, Pipeline Analysis) – Growth, Share, Opportunities & Competitive Analysis, 2016 -2022
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Name: Chris Smith
Designation: Global Sales Manager
Web: Credence Research
Release ID: 5516